Education
About Us
Working with TipRanks
Follow Us
Vicore Pharma Holding AB (SE:VICO)
:VICO
Total Valuation
Vicore Pharma Holding AB has a market cap or net worth of kr2.76B. The enterprise value is kr1.76B.
Market Capkr2.76B
Enterprise Valuekr1.76B
Share Statistics
Vicore Pharma Holding AB has 281,525,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding281,525,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vicore Pharma Holding AB’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -41.26%.
Return on Equity (ROE)-0.44
Return on Assets (ROA)-0.39
Return on Invested Capital (ROIC)-41.26%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee115.67K
Profits Per Employee-14.47M
Employee Count33
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Vicore Pharma Holding AB is ―. Vicore Pharma Holding AB’s PEG ratio is -0.03.
PE Ratio―
PS Ratio710.16
PB Ratio2.47
Price to Fair Value2.47
Price to FCF0.00
Price to Operating Cash Flow-7.71
PEG Ratio-0.03
Income Statement
In the last 12 months, Vicore Pharma Holding AB had revenue of 3.82M and earned -477.47M in profits. Earnings per share was -1.99.
Revenue3.82M
Gross Profit3.82M
Operating Income-454.44M
Pretax Income-477.47M
Net Income-477.47M
EBITDA-454.44M
Earnings Per Share (EPS)-1.99
Cash Flow
In the last 12 months, operating cash flow was -274.04M and capital expenditures 81.48M, giving a free cash flow of -192.56M billion.
Operating Cash Flow-274.04M
Free Cash Flow-192.56M
Free Cash Flow per Share-0.68
Dividends & Yields
Vicore Pharma Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change33.11%
50-Day Moving Average10.96
200-Day Moving Average10.33
Relative Strength Index (RSI)40.92
Average Volume (3m)520.11K
Important Dates
Vicore Pharma Holding AB upcoming earnings date is May 6, 2026, TBA (Confirmed).
Last Earnings DateFeb 27, 2026
Next Earnings DateMay 6, 2026
Ex-Dividend Date―
Financial Position
Vicore Pharma Holding AB as a current ratio of 10.31, with Debt / Equity ratio of 0.00%
Current Ratio10.31
Quick Ratio10.31
Debt to Market Cap0.00
Net Debt to EBITDA1.27
Interest Coverage Ratio-9.03
Taxes
In the past 12 months, Vicore Pharma Holding AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Vicore Pharma Holding AB EV to EBITDA ratio is -4.69, with an EV/FCF ratio of 0.00.
EV to Sales558.69
EV to EBITDA-4.69
EV to Free Cash Flow0.00
EV to Operating Cash Flow-5.70
Balance Sheet
Vicore Pharma Holding AB has kr1.17B in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr1.17B billion.
Cash & Marketable Securitieskr1.17B
Total Debtkr0.00
Net Cashkr1.17B
Net Cash Per Sharekr4.15
Tangible Book Value Per Sharekr4.57
Margins
Gross margin is 80.09%, with operating margin of -11905.82%, and net profit margin of -12509.14%.
Gross Margin80.09%
Operating Margin-11905.82%
Pretax Margin-12509.14%
Net Profit Margin-12509.14%
EBITDA Margin-11905.82%
EBIT Margin-11905.82%
Analyst Forecast
The average price target for Vicore Pharma Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-91.85%
EPS Growth Forecast-6.65%